Amiodarone Tablets and Patiromer Sorbitex Calcium
Determining the interaction of Amiodarone Tablets and Patiromer Sorbitex Calcium and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.GENERALLY AVOID: Amiodarone can cause dose-related prolongation of the QT interval. Theoretically, coadministration with agents that can produce hypokalemia and/or hypomagnesemia (e.g., potassium-wasting diuretics, amphotericin B, cation exchange resins, stimulant laxatives) may result in elevated risk of ventricular arrhythmias, including ventricular tachycardia and torsades de pointes, because of additive arrhythmogenic potential. MANAGEMENT: Coadministration of amiodarone with medications that can cause potassium and/or magnesium disturbances should generally be avoided. Serum electrolytes should be evaluated and any abnormalities corrected prior to initiating therapy with amiodarone. Patients should be advised to seek medical attention if they experience symptoms that could indicate the occurrence of torsades de pointes such as dizziness, palpitations, or syncope. References Antonelli D, Atar S, Freedberg NA, Rosenfeld T "Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions." Isr Med Assoc J 7 (2005): 163-5 "Product Information. Amiodarone Hydrochloride (amiodarone)." Bedford Laboratories, Bedford, OH.
Professional:GENERALLY AVOID: Amiodarone can cause dose-related prolongation of the QT interval. Theoretically, coadministration with agents that can produce hypokalemia and/or hypomagnesemia (e.g., potassium-wasting diuretics, amphotericin B, cation exchange resins, stimulant laxatives) may result in elevated risk of ventricular arrhythmias, including ventricular tachycardia and torsades de pointes, because of additive arrhythmogenic potential.
MANAGEMENT: Coadministration of amiodarone with medications that can cause potassium and/or magnesium disturbances should generally be avoided. Serum electrolytes should be evaluated and any abnormalities corrected prior to initiating therapy with amiodarone. Patients should be advised to seek medical attention if they experience symptoms that could indicate the occurrence of torsades de pointes such as dizziness, palpitations, or syncope.
- Antonelli D, Atar S, Freedberg NA, Rosenfeld T "Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions." Isr Med Assoc J 7 (2005): 163-5
- "Product Information. Amiodarone Hydrochloride (amiodarone)." Bedford Laboratories, Bedford, OH.
Generic Name: amiodarone
Brand name: Pacerone, Cordarone, Nexterone
Synonyms: Amiodarone
Generic Name: patiromer
Brand name: Veltassa
Synonyms: Patiromer
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Amiodarone Tablets-Pavacot
- Amiodarone Tablets-Paxil
- Amiodarone Tablets-Paxil (Paroxetine Suspension)
- Amiodarone Tablets-Paxil (Paroxetine Tablets)
- Amiodarone Tablets-Paxil CR
- Amiodarone Tablets-Pazopanib
- Patiromer Sorbitex Calcium-Amitiza
- Patiromer Sorbitex Calcium-Amitriptyline
- Patiromer Sorbitex Calcium-Amitriptyline and chlordiazepoxide
- Patiromer Sorbitex Calcium-Amitriptyline and perphenazine
- Patiromer Sorbitex Calcium-Amitriptyline Hydrochloride
- Patiromer Sorbitex Calcium-Amjevita Subcutaneous